Safety of Tralokinumab for the Treatment of Atopic Dermatitis in Patients with Up to 4.5 Years of Treatment: An Updated Integrated Analysis of Eight Clinical Trials . SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 2, p. s375, 2024. DOI: 10.25251/skin.8.supp.375. Disponível em: https://skin.dermsquared.com/skin/article/view/2675. Acesso em: 20 jan. 2026.